• Arch Surg Chicago · Jun 2004

    Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.

    • Kathie-Ann Joseph, Mahmoud El-Tamer, Ian Komenaka, Andrea Troxel, Beth Ann Ditkoff, and Freya Schnabel.
    • Department of Surgery, Columbia Presbyterian Comprehensive Breast Center, New York Presbyterian Hospital, NY, USA. kpr2@columbia.edu
    • Arch Surg Chicago. 2004 Jun 1; 139 (6): 648-51.

    HypothesisThe presence of nonsentinel lymph node (NSLN) metastasis after having a positive sentinel lymph node dissection finding is associated with tumor size and stage, the presence of lymphovascular invasion, micrometastasis, and extranodal extension.DesignRetrospective case series.SettingUniversity hospital.PatientsFour hundred seven consecutive patients at a single institution who underwent sentinel lymph node dissection as part of breast conservation or mastectomy with biopsy-proved cancer.InterventionCompletion axillary lymph node dissection and definitive therapy.Main Outcome MeasuresSentinel node metastasis, NSLN metastasis, tumor size and stage, lymphovacular invasion, micrometastasis, extronodal extension, histological tumor characteristics, and number of sentinel nodes removed.ResultsIn a univariate analysis, size of the primary tumor and extranodal extension were associated with having positive NSLN findings. The presence of micrometastasis was associated with negative NSLN findings. When all factors were included in a logistic regression analysis, the significant predictor of NSLN metastasis was extranodal extension (P =.002). Lymphovascular invasion was not associated with positive NSLN findings (P =.11). The number of sentinel nodes removed also had no bearing on the status of the NSLNs (P =.37).ConclusionsAlthough primary tumor size and micrometastases correlate with the status of the NSLNs, extranodal extension is the most important independent predictor of NSLN metastasis. These findings may ultimately spare patients a full axillary lymph node dissection. However, pending results of larger clinical trials, full axillary lymph node dissection is still recommended for patients with sentinel lymph node metastases.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.